Perrigo: stocks, financial statements

Disable ads for free
Dividends News
Favorites

Perrigo Co. Plc is a healthcare company, which engages in the production of over-the-counter consumer goods and specialty pharmaceutical products. It operates through the following segments: Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals. The Consumer Healthcare Americas segment comprises the U.S., Mexico and Canada consumer healthcare business. The Consumer Healthcare International segment includes branded consumer healthcare business primarily in Europe and consumer focused businesses in the U.K., Australia, and Israel. The Prescription Pharmaceuticals refers to the U.S. prescription pharmaceuticals business. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland.

  • PRGO Ticker
  • NYSE Exchange
  • 10,600 Employees
3 rated
  • $48.03, +$0.10 (+0.21%) Previous Close
  • 332,731 Previous Volume
  • $40.13 / $59.79 52 week low / high
  • -19.67% Percent off 52 week high
  • 2020-11-27 Updated
  • 1.82% Dividend Yield (trailing)
  • 1.85% Dividend Yield (forward)
  • 0 Public float
  • 136,491,307 Outstanding shares
  • 0.00 P/E
  • 6.56 B Market Cap
Disable ads for free

Financial statements — Perrigo

The information is not 100% up-to-date. There may be errors or missing information. Some information is often missing, and, although there are almost no errors, I can't rule them out. Right now, I'm looking for a supplier of high-quality information, but so far what I'm finding is expensive (about $2000 a year). You can help my project here.
19 ← 15 2019 2018 2017 2016 2015
Total Revenue
4.8B 4.7B 4.9B 5.3B 5.5B
Cost Of Revenue
3.1B 2.9B 3B 3.2B 3.3B
Gross Profit
1.8B 1.8B 2B 2B 2.2B
Research and Development
190M 220M 160M 180M 180M
Selling General and Admin
1.2B 1.1B 1.1B 1.2B 1.3B
Operating Expense
4.4B 4.2B 4.3B 4.6B 4.8B
Operating Income
440M 480M 670M 660M 730M
Other Income Expense Net
-270M -190M -390M -5.5B -780M
EBIT
440M 480M 670M 660M 730M
Interest Income
130M 120M 160M 210M 130M
Pretax Income
170M 290M 280M -4.8B -46M
Income Tax
25M 160M 160M -840M -58M
Minority Interest
0 0 0 0 0
Net Income
150M 130M 120M -4B 11M
Net Income Basic
150M 130M 120M -4B 11M
19 ← 15 2019 2018 2017 2016 2015
Current cash
350M 550M 680M 620M 420M
Short term investments
6.6M 9.4M 17M 38M
Receivables
1.3B 1.1B 1.1B 1.2B 1.2B
Inventory
970M 880M 810M 800M 840M
Other current assets
160M 370M 190M 170M 290M
Current assets
2.8B 2.9B 2.8B 2.8B 2.7B
Long term investments
20M 20M 11M 2.4B 52M
Property plant equipment
1B 830M 830M 870M 890M
Goodwill
4.1B 4B 4.2B 4B 5.4B
Intangible assets
3B 2.9B 3.4B 3.5B 10B
Other assets
380M 340M 400M 200M 180M
Total assets
11B 11B 12B 14B 19B
Accounts payable
520M 470M 450M 470M 550M
Current long term debt
3.4M 190M 70M 570M 1B
Other current liabilities
750M 780M 800M 760M 830M
Total current liabilities
1.3B 1.5B 1.4B 1.8B 2.5B
Long term debt
3.5B 3.1B 3.3B 5.2B 5B
Other liabilities
380M 440M 430M 390M 310M
Minority Interest
0 0 0 0 0
Total Liabilities
5.5B 5.3B 5.5B 7.9B 9.4B
Common stock
140M 140M 140M 140M 140M
Retained earning
-1.7B -1.8B -2B -2.1B 1.9B
Treasury stock
250K 200K 1M 6.4M 6M
Capital surplus
Shareholder equity
5.8B 5.7B 6.2B 6B 10B
Net tangible assets
-7.2B -6.7B -6.9B -6.7B 4.7B
19 ← 15 2019 2018 2017 2016 2015
Net Income
150M 130M 120M -4B 11M
Depreciation
400M 420M 440M 460M 330M
Changes in receivables
-200M 58M 45M 17M
Changes in inventories
-67M -99M -16M 100M -70M
Cash change
-200M -130M 56M 200M -370M
Cash flow
390M 590M 690M -3.7B 320M
Capital expenditures
-290M -140M -89M -170M -78M
Investments
-7.5M 2.2B 4.5M
Investing activity other
-15M -3.6M -5M
Total investing cash flows
-600M -130M 2.3B -180M -870M
Dividends paid
-110M -100M -91M -83M -36M
Net borrowings
120M -58M -2.6B -170M 730M
Other financing cash flows
-10M -10M -110M -9.3M -8.4M
Cash flow financing
1.8M -570M -3B -270M 190M
Exchange rate effect
9.7M -22M 24M -6.7M -10M
Disable ads for free
Disable ads for free